Recent advances in biliary atresia: Prospects for novel therapies

Expert Opinion on Investigational Drugs

Volumn 17, Issue 12, 2008, Pages 1911-1924

  Haber, Barbara A ^a   Erlichman, Jessi ^b   Loomes, Kathleen M ^b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b NONE

Author keywords

Biliary atresia; Hepatoportoenterostomy; Kasai procedure

Indexed keywords

ALPHA TOCOPHEROL; AMINOGLYCOSIDE; AQUATMEPHYTON; CALCIFEDIOL; CEPHALOSPORIN; COLECALCIFEROL; CORTICOSTEROID; COTRIMOXAZOLE; DIURETIC AGENT; ERGOCALCIFEROL; FAT; INCHINKO TO; MENADIONE; MENAQUINONE; METHYLPREDNISOLONE; NEOMYCIN; PENICILLIN DERIVATIVE; PHYTOMENADIONE; RECOMBINANT GAMMA INTERFERON; RETINOL; TOCOFERSOLAN; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID; VITAMIN D; VITAMIN;

ADJUVANT THERAPY; ASCITES; ATAXIA; BILE DUCT ATRESIA; BILE FLOW; BILIARY CIRRHOSIS; BONE LESION; CALORIC INTAKE; CHOLANGITIS; CHOLESTASIS; CLINICAL COMPETENCE; CLINICAL FEATURE; CLINICAL TRIAL; DIARRHEA; DIET SUPPLEMENTATION; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG MEGADOSE; ENERGY EXPENDITURE; ESCHERICHIA COLI; FATIGUE; GROUPS BY AGE; HUMAN; HYPERCALCEMIA; HYPOCALCEMIA; HYPOPHOSPHATEMIA; INTRACRANIAL PRESSURE; KIDNEY CALCIFICATION; LIVER FIBROSIS; LIVER GRAFT REJECTION; LIVER TOXICITY; LIVER TRANSPLANTATION; MALABSORPTION; MEDICAL EXPERT; MUSCLE WEAKNESS; NAUSEA AND VOMITING; NONHUMAN; NUTRITION; OSTEOMALACIA; OUTCOME ASSESSMENT; PARACENTESIS; PORTAL HYPERTENSION; POSTOPERATIVE CARE; PROTEIN INTAKE; RETINOL DEFICIENCY; REVIEW; RICKETS; SIDE EFFECT; TETANY; TREATMENT FAILURE; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ANIMAL; BODY WEIGHT; PATHOLOGY;

ANIMALS; BILIARY ATRESIA; BODY WEIGHT; ENERGY INTAKE; HUMANS; VITAMINS;

EID: 58149374000     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543780802514120     Document Type: Review

References (101)

1. Haber BA, Russo P. Biliary atresia. Gastroenterol Clin North Am 2003;32(3): 891-911 (Pubitemid 37185840)
2. De Matos V, et al. Does "cystic" biliary atresia represent a distinct clinical and etiological subgroup? A series of three cases. Pediatr Dev Pathol 2005;8(6):725-731
3. Muise AM, et al. Biliary atresia with choledochal cyst: implications for classification. Clin Gastroenterol Hepatol 2006;4(11):1411-1414
4. Holmes JB. Congenital obliteration of the bile ducts. Am J Dis Child 1916;11:405-431
5. Ladd WE. Congenital obstruction of the bile ducts. Ann Surg 1935;102:742-751
6. Ladd WE. Congenital atresia and stenosis of the bile ducts. JAMA 1928;91:1082-1085
7. Kasai M, Asakura Y. [Surgery of congenital obstruction of the bile ducts in our clinics]. Shujutsu 1968;22(12):1228-1235
8. Kasai M. Treatment of biliary atresia with special reference to hepatic porto-enterostomy and its modifications. Prog Pediatr Surg 1974;6:5-52
9. Kasai M, et al. Technique and results of operative management of biliary atresia. World J Surg 1978;2(5):571-579 (Pubitemid 9108412)
10. Karrer FM, et al. Biliary atresia registry, 1976 to 1989. J Pediatr Surg 1990;25(10):1076-80; discussion 1081
11. Schreiber RA, et al. Biliary atresia: the Canadian experience. J Pediatr 2007;151(6):659-665, 665 e1 (Pubitemid 350116135)
12. Hsiao CH, et al. Universal screening for biliary atresia using an infant stool color card in Taiwan. Hepatology 2008;47(4):1233-1240
13. Sokol RJ, et al. Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop. Hepatology 2007;46(2):566-581
14. Mushtaq I, et al. Screening of newborn infants for cholestatic hepatobiliary disease with tandem mass spectrometry. BMJ 1999;319(7208):471-477
15. American Academy of Pediatrics. Recommendations for Preventitive Pediatric Health Care. Pediatrics 2007;120(6):1376
16. Kasai M, Suzuki S. A new operation for "non-correctable" biliary atresia - portoenterostomy. 1959;13:733-739
17. Davenport M, et al. Surgery for biliary atresia-is there a European consensus? Eur J Pediatr Surg 2007;17(3):180-183
18. Available from: http://www.barcnetwork.org/
19. Matsuo S, et al. Hazards of hepatic portocholecystostomy in biliary atresia. Eur J Pediatr Surg 2001;11(1):19-23 (Pubitemid 32385554)
20. Martinez-Ferro M, Esteves E, Laje P. Laparoscopic treatment of biliary atresia and choledochal cyst. Semin Pediatr Surg 2005;14(4):206-215 (Pubitemid 41443365)
21. Meehan JJ, Elliott S, Sandler A. The robotic approach to complex hepatobiliary anomalies in children: preliminary report. J Pediatr Surg 2007;42(12):2110-2114 (Pubitemid 350235518)
22. Tsao K, et al. Comparison of drainage techniques for biliary atresia. J Pediatr Surg 2003;38(7):1005-1007 (Pubitemid 36828863)
23. Davenport M, et al. Seamless management of biliary atresia in England and Wales (1999-2002). Lancet 2004;363(9418):1354-1357
24. Chardot C, et al. Prognosis of biliary atresia in the era of liver transplantation: French national study from 1986 to 1996. Hepatology 1999;30(3):606-611
25. De Russo PA, et al. Growth failure and outcomes in infants with biliary atresia: a report from the Biliary Atresia Research Consortium. Hepatology 2007;46(5):1632-1638
26. Greer R, et al. Body composition and components of energy expenditure in children with end-stage liver disease. J Pediatr Gastroenterol Nutr 2003;36(3):358-363 (Pubitemid 39274607)
27. Pierro A, et al. Resting energy expenditure is increased in infants and children with extrahepatic biliary atresia. J Pediatr Surg 1989;24(6):534-538 (Pubitemid 19145736)
28. Novy MA, Schwarz KB. Nutritional considerations and management of the child with liver disease. Nutrition 1997;13(3):177-184 (Pubitemid 27184884)
29. Parker P, Stroop S, Greene H. A controlled comparison of continuous versus intermittent feeding in the treatment of infants with intestinal disease. J Pediatr 1981;99(3):360-364 (Pubitemid 11029925)
30. Ferry GD, Selby M, Pietro TJ. Clinical response to short-term nasogastric feeding in infants with gastroesophageal reflux and growth failure. J Pediatr Gastroenterol Nutr 1983;2(1):57-61
31. Baker A, et al. Guidelines for nutritional care for infants with cholestatic liver disease before liver transplantation. Pediatr Transplant 2007;11(8):825-834
32. Feranchak AP, Sokol R. Medical and nutritional management of cholestasis in infants and children, in liver disease in children, FJ Suchy, RJ Sokol, and WF Balistreri, editors, 2007, Cambridge University Press: New York. p. 190-231
33. Sokal EM, et al. Branched chain amino acids improve body composition and nitrogen balance in a rat model of extra hepatic biliary atresia. Pediatr Res 1996;40(1):66-71
34. Chin SE, et al. The nature of malnutrition in children with end-stage liver disease awaiting orthotopic liver transplantation. Am J Clin Nutr 1992;56(1):164-168
35. Mager DR, et al. Branched-chain amino acid needs in children with mild-to-moderate chronic cholestatic liver disease. J Nutr 2006;136(1):133-139 (Pubitemid 43156498)
36. Kaufman SS, et al. Influence of portagen and pregestimil on essential fatty acid status in infantile liver disease. Pediatrics 1992;89(1):151-154
37. Kaufman SS, et al. Nutritional support for the infant with extrahepatic biliary atresia. J Pediatr 1987;110(5):679-686 (Pubitemid 17074732)
38. Report of the 87th Ross Conference; 1984
39. Andrews WS, et al. Fat soluble vitamin deficiency in biliary atresia. J Pediatr Surg 1981;16(3): 284-290 (Pubitemid 11078666)
40. International Food Information Council. Dietary Reference Intakes: an Update. August 2002. Available from http://www.ific.org/publications/other/ driupdateom.cfm [Last accessed 17 October 2008]
41. Fukui Y, et al. Vitamin A status in biliary atresia: intestinal absorption and liver storage of retinol. J Pediatr Surg 1993;28(11):1502-1504 (Pubitemid 23345555)
42. Ong DE, Amedee-Manesme O. Liver levels of vitamin A and cellular retinol-binding protein for patients with biliary atresia. Hepatology 1987;7(2):253-256 (Pubitemid 17062713)
43. Amedee-Manesme O, et al.[Vitamin A status in liver diseases in children. Study based on 79 hepatic biopsies]. Arch Fr Pediatr 1985;42(Suppl 1):591-595
44. Mourey MS, Siegenthaler G, Amedee-Manesme O.Regulation of metabolism of retinol-binding protein by vitamin A status in children with biliary atresia. Am J Clin Nutr 1990;51(4):638-643
45. Amedee-Manesme O, et al. Short- and long-term vitamin A treatment in children with cholestasis. Am J Clin Nutr 1988;47(4):690-693 (Pubitemid 18114431)
46. Heubi JE, Hollis BW, Tsang RC. Bone disease in chronic childhood cholestasis. II. Better absorption of 25-OH vitamin D than vitamin D in extrahepatic biliary atresia. Pediatr Res 1990;27(1):26-31
47. Argao EA, Specker BL, Heubi JE. Bone mineral content in infants and children with chronic cholestatic liver disease. Pediatrics 1993;91(6):1151-1154 (Pubitemid 23165794)
48. Kimura S, et al. Vitamin D metabolism in biliary atresia: intestinal absorptions of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3. J Pediatr Gastroenterol Nutr 1988;7(3):341-346 (Pubitemid 18123828)
49. Argao EA, et al. d-Alpha-tocopheryl polyethylene glycol-1000 succinate enhances the absorption of vitamin D in chronic cholestatic liver disease of infancy and childhood. Pediatr Res 1992;31(2):146-150
50. Tazawa Y, et al. Serum vitamin E levels in children with corrected biliary atresia. Am J Clin Nutr 1984;40(2):246-250 (Pubitemid 14065380)
51. Sokol RJ, et al. Comparison of vitamin E and 25-hydroxyvitamin D absorption during childhood cholestasis. J Pediatr 1983;103(5):712-717 (Pubitemid 14235431)
52. Cynamon HA, Norcross K, Isenberg JN. Evoked potential abnormalities in children with chronic cholestasis. Hepatology 1988;8(6):1596-1601 (Pubitemid 19021893)
53. Sokol RJ, et al. Multicenter trial of d-alpha-tocopheryl polyethylene glycol 1000 succinate for treatment of vitamin E deficiency in children with chronic cholestasis. Gastroenterology 1993;104(6):1727-1735
54. Sokol RJ, et al. Improved neurologic function after long-term correction of vitamin E deficiency in children with chronic cholestasis. N Engl J Med 1985;313(25):1580-1586 (Pubitemid 16177398)
55. Mas N, et al. Ursodeoxycholic acid treatment improves hepatocyte ultrastructure in rat liver fibrosis. World J Gastroenterol 2008;14(7):1108-1111 (Pubitemid 351325013)
56. Flamm S, Kaplan M. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis, in UpToDate, Bonis P, Editor; 2008
57. Lai HS, et al. Long-term prognosis and factors affecting biliary atresia from experience over a 25 year period. Chang Gung Med J 2006;29(3):234-239
58. Ernest Van Heurn LW, Saing H, Tam PK. Cholangitis after hepatic portoenterostomy for biliary atresia: a multivariate analysis of risk factors. J Pediatr 2003;142(5):566-571 (Pubitemid 36623570)
59. Shneider BL, et al. A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J Pediatr 2006;148(4):467-474
60. Sasaki H, et al. Problems during and after pregnancy in female patients with biliary atresia. J Pediatr Surg 2007;42(8):1329-1332 (Pubitemid 47238319)
61. Wu ET, et al. Bacterial cholangitis in patients with biliary atresia: impact on short-term outcome. Pediatr Surg Int 2001;17(5-6):390-395
62. Luo Y, Zheng S. Current concept about postoperative cholangitis in biliary atresia. World J Pediatr 2008;4(1):14-19 (Pubitemid 351234084)
63. Bu LN, et al. Prophylactic oral antibiotics in prevention of recurrent cholangitis after the Kasai portoenterostomy. J Pediatr Surg 2003;38(4):590-593 (Pubitemid 36417800)
64. Sartorelli KH, et al. The intussusception antireflux valve is ineffective in preventing cholangitis in biliary atresia. J Pediatr Surg 1996;31(3):403-406 (Pubitemid 26106140)
65. Ogasawara Y, et al. The intussusception antireflux valve is ineffective for preventing cholangitis in biliary atresia: a prospective study. J Pediatr Surg 2003;38(12):1826-1829 (Pubitemid 37505423)
66. Meyers RL, et al. High-dose steroids, ursodeoxycholic acid, and chronic intravenous antibiotics improve bile flow after Kasai procedure in infants with biliary atresia. J Pediatr Surg 2003;38(3):406-411 (Pubitemid 36278701)
67. Dillon PW, et al. Immunosuppression as adjuvant therapy for biliary atresia. J Pediatr Surg 2001;36(1):80-85 (Pubitemid 32044319)
68. Escobar MA, et al. Effect of corticosteroid therapy on outcomes in biliary atresia after Kasai portoenterostomy. J Pediatr Surg 2006;41(1):99-103; discussion 99-103 (Pubitemid 43067500)
69. Petersen C, et al. Postoperative high-dose steroids do not improve mid-term survival with native liver in biliary atresia. Am J Gastroenterol 2008;103(3):712-719
70. Altman RP, et al. A multivariable risk factor analysis of the portoenterostomy (Kasai) procedure for biliary atresia: twenty-five years of experience from two centers. Ann Surg 1997;226(3):348-53; discussion 353-355
71. Balistreri WF, et al. Biliary atresia: current concepts and research directions. Summary of a symposium. Hepatology 1996;23(6):1682-1692
72. Okamoto T, et al. Pretransplant risk factors and optimal timing for living-related liver transplantation in biliary atresia: experience of one Japanese children's hospital and transplantation center. J Pediatr Surg 2008;43(3):489-494
73. Ryckman F, et al. Improved survival in biliary atresia patients in the present era of liver transplantation. J Pediatr Surg 1993;28(3):382-5; discussion 386 (Pubitemid 23091048)
74. Barshes NR, et al. Orthotopic liver transplantation for biliary atresia: the U.S. experience. Liver Transpl 2005;11(10):1193-1200
75. Fouquet V, et al. Long-term outcome of pediatric liver transplantation for biliary atresia: a 10-year follow-up in a single center. Liver Transpl 2005;11(2):152-160
76. Chen CL, et al. Living donor liver transplantation for biliary atresia: a single-center experience with first 100 cases. Am J Transplant 2006;6(11):2672-2679 (Pubitemid 44571687)
77. Otte JB. History of pediatric liver transplantation. Where are we coming from? Where do we stand? Pediatr Transplant 2002;6(5):378-387
78. Bezerra JA, et al. Genetic induction of proinflammatory immunity in children with biliary atresia. Lancet 2002;360(9346):1653-1659
79. Zhang DY, et al. Coordinate expression of regulatory genes differentiates embryonic and perinatal forms of biliary atresia. Hepatology 2004;39(4):954-962
80. Mack CL, et al. Biliary atresia is associated with CD4+ Th1 cell-mediated portal tract inflammation. Pediatr Res 2004;56(1):79-87
81. Mack CL, et al. Oligoclonal expansions of CD4+ and CD8+ T-cells in the target organ of patients with biliary atresia. Gastroenterology 2007;133(1):278-287
82. Mack CL, et al. Armed CD4+ Th1 effector cells and activated macrophages participate in bile duct injury in murine biliary atresia. Clin Immunol 2005;115(2):200-209
83. Jafri M, et al. Cholangiocyte expression of {alpha}2{beta}1-integrin confers susceptibility to rotavirus-induced experimental biliary atresia. Am J Physiol Gastrointest Liver Physiol 2008;295(1):G16-26
84. Czech-Schmidt G, et al. Immunological gap in the infectious animal model for biliary atresia. J Surg Res 2001;101(1):62-67 (Pubitemid 33030108)
85. Carvalho E, et al. Analysis of the biliary transcriptome in experimental biliary atresia. Gastroenterology 2005;129(2):713-717
86. Shivakumar P, et al. Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-gamma in experimental biliary atresia. J Clin Invest 2004;114(3):322-329 (Pubitemid 39071604)
87. Shivakumar P, et al. Effector role of neonatal hepatic CD8+ lymphocytes in epithelial injury and autoimmunity in experimental biliary atresia. Gastroenterology 2007;133(1):268-277
88. Tucker RM, et al. Progressive biliary destruction is independent of a functional tumor necrosis factor-alpha pathway in a rhesus rotavirus-induced murine model of biliary atresia. Viral Immunol 2007;20(1):34-43
89. Mohanty SK, et al. Loss of interleukin-12 modifies the pro-inflammatory response but does not prevent duct obstruction in experimental biliary atresia. BMC Gastroenterol 2006;6:14
90. Erickson N, et al. Temporal-spatial activation of apoptosis and epithelial injury in murine experimental biliary atresia. Hepatology 2008;47(5):1567-1577
91. Mack CL, et al. Cellular and humoral autoimmunity directed at bile duct epithelia in murine biliary atresia. Hepatology 2006;44(5):1231-1239
92. Davenport M, et al. Immunohistochemistry of the liver and biliary tree in extrahepatic biliary atresia. J Pediatr Surg 2001;36(7):1017-1025 (Pubitemid 32619749)
93. Davenport M, et al. Soluble adhesion molecule profiling in preoperative infants with biliary atresia. J Pediatr Surg 2005;40(9):1464-1469 (Pubitemid 41248012)
94. Kobayashi H, et al. Serum concentration of adhesion molecules in ostoperative biliary atresia patients: relationship to disease activity and cirrhosis. J Pediatr Surg 2001;36(8):1297-1301 (Pubitemid 32705728)
95. Diaz R, et al. Evidence for the epithelial to mesenchymal transition in biliary atresia fibrosis. Hum Pathol 2008;39(1):102-115
96. Tamura T, et al. Inchin-ko-to prevents medium-term liver fibrosis in postoperative biliary atresia patients. Pediatr Surg Int 2007;23(4):343-347
97. Iinuma Y, et al. Effects of the herbal medicine Inchinko-to on liver function in postoperative patients with biliary atresia-a pilot study. J Pediatr Surg 2003;38(11):1607-1611 (Pubitemid 37413858)
98. Hsieh CS, et al. Evaluation of hepatocyte growth factor in patients with biliary atresia. J Pediatr Surg 2008;43(7):1333-1337 (Pubitemid 351970527)
99. Vejchapipat P, et al. Serum hepatocyte growth factor and clinical outcome in biliary atresia. J Pediatr Surg 2004;39(7):1045-1049 (Pubitemid 38881161)
100. Narkewicz MR, et al. Connective tissue growth factor expression is increased in biliary epithelial cells in biliary atresia. J Pediatr Surg 2005;40(11):1721-1725 (Pubitemid 41625735)
101. Feng J, et al. Rotavirus-induced murine biliary atresia is mediated by nuclear factor-kappaB. J Pediatr Surg 2005;40(4):630-636 (Pubitemid 40504005)